BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3828735)

  • 1. Mechanism of the haemostatic effect of ethanolamine oleate in the injection sclerotherapy for oesophageal varices.
    Kang JH; Kambayashi J; Sakon M; Shiozaki H; Ogawa Y; Ohshiro T; Mori T
    Br J Surg; 1987 Jan; 74(1):50-3. PubMed ID: 3828735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercoagulopathy after repeated injection of 5% ethanolamine oleate to sclerose esophageal varices.
    Hashizume M; Yamaga H; Kitano S; Sugimachi K
    Hepatogastroenterology; 1990 Dec; 37(6):565-8. PubMed ID: 2289769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet aggregability after endoscopic intravariceal injection of 5 per cent ethanolamine oleate into oesophageal varices.
    Yamaga H; Hashizume M; Kitano S; Higashi H; Sugimachi K
    Br J Surg; 1989 Sep; 76(9):939-42. PubMed ID: 2804591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
    Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
    Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial.
    Kitano S; Iso Y; Koyanagi N; Higashi H; Sugimachi K
    Hepatogastroenterology; 1987 Feb; 34(1):19-23. PubMed ID: 3552917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of 5% ethanolamine oleate versus 5% sodium morrhuate for sclerotherapy of oesophageal varices.
    Kitano S; Wada H; Yamaga H; Hashizume M; Koyanagi N; Iwanaga T; Iso Y; Sugimachi K
    J Gastroenterol Hepatol; 1991; 6(5):476-80. PubMed ID: 1932669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human thrombin plus 5 per cent ethanolamine oleate injected to sclerose oesophageal varices: a prospective randomized trial.
    Kitano S; Hashizume M; Yamaga H; Wada H; Iso Y; Iwanaga T; Sugimachi K
    Br J Surg; 1989 Jul; 76(7):715-8. PubMed ID: 2765808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial of sclerosing agents in patients with oesophageal varices.
    Kitano S; Iso Y; Yamaga H; Hashizume M; Higashi H; Sugimachi K
    Br J Surg; 1988 Aug; 75(8):751-3. PubMed ID: 3048533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective randomized study comparing the effects of large and small volumes of the sclerosant 5% ethanolamine oleate injected into esophageal varices.
    Iso Y; Kitano S; Iwanaga T; Koyanagi N; Sugimachi K
    Endoscopy; 1988 Nov; 20(6):285-8. PubMed ID: 3229387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study.
    Oho K; Iwao T; Sumino M; Toyonaga A; Tanikawa K
    Endoscopy; 1995 Jun; 27(5):349-54. PubMed ID: 7588347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of 50% alcohol and ethanolamine oleate for oesophageal sclerotherapy.
    Vij JC; Kumar N; Kumar A; Anand BS; Broor SL
    Indian J Gastroenterol; 1988 Oct; 7(4):211-3. PubMed ID: 3053436
    [No Abstract]   [Full Text] [Related]  

  • 12. Sclerotherapy for esophageal varices.
    Benjamin SB
    DICP; 1990 Nov; 24(11 Suppl):S47-50. PubMed ID: 2270696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in blood coagulation and fibrinolysis following endoscopic injection sclerotherapy].
    Kawashima Y
    Nihon Shokakibyo Gakkai Zasshi; 1990 Feb; 87(2):163-72. PubMed ID: 2325296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balloon-Occluded Retrograde Transvenous Obliteration for the Treatment of Gastric Varices: Polidocanol Foam Versus Liquid Ethanolamine Oleate.
    Itou C; Koizumi J; Hashimoto T; Myojin K; Kagawa T; Mine T; Imai Y
    AJR Am J Roentgenol; 2015 Sep; 205(3):659-66. PubMed ID: 26295655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endoscopic sclerotherapy of esophageal varices in pediatric patients].
    Salvatierra A; Granella L; Guevara ML; Barrios M; GarcĂ­a MI; Salvatierra L
    G E N; 1992; 46(1):1-3. PubMed ID: 1305111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ethanolamine oleate as a sclerosing solution in the therapy of esophageal varices].
    Tsutsumi M; Takada A
    Nihon Rinsho; 1990 Apr; 48(4):713-7. PubMed ID: 2366357
    [No Abstract]   [Full Text] [Related]  

  • 17. Repeated injection sclerotherapy is preferable to combined therapy with variceal ligation to avoid recurrence of esophageal varices:--a prospective randomized trial.
    Iso Y; Kawanaka H; Tomikawa M; Matsumata T; Kitano S; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):467-71. PubMed ID: 9164520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injection sclerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate.
    Miyazaki S; Yoshida T; Harada T; Shigemitsu T; Takeo Y; Okita K
    Hepatogastroenterology; 1998; 45(22):1155-8. PubMed ID: 9756025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transvenous sclerotherapy for huge oesophagogastric varices using open injection sclerotherapy.
    Kitano S; Baatar D; Bandoh T; Yoshida T; Tsuboi S; Matsumoto T
    Br J Surg; 2000 Jul; 87(7):926-30. PubMed ID: 10931030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haptoglobin prevents renal dysfunction associated with intravariceal infusion of ethanolamine oleate.
    Miyoshi H; Ohshiba S; Matsumoto A; Takada K; Umegaki E; Hirata I
    Am J Gastroenterol; 1991 Nov; 86(11):1638-41. PubMed ID: 1951242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.